Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Evaluation of the effects of chemotherapy-induced fatigue and pharmacological interventions in multiple mouse behavioral assays.

Dougherty JP, Springer DA, Cullen MJ, Gershengorn MC.

Behav Brain Res. 2019 Mar 15;360:255-261. doi: 10.1016/j.bbr.2018.12.011. Epub 2018 Dec 7.

PMID:
30529403
2.

Taltirelin alleviates fatigue-like behavior in mouse models of cancer-related fatigue.

Dougherty JP, Wolff BS, Cullen MJ, Saligan LN, Gershengorn MC.

Pharmacol Res. 2017 Oct;124:1-8. doi: 10.1016/j.phrs.2017.07.012. Epub 2017 Jul 15.

3.
4.

An Evaluation of Antibiotic Prescribing Practices Upon Hospital Discharge.

Scarpato SJ, Timko DR, Cluzet VC, Dougherty JP, Nunez JJ, Fishman NO, Hamilton KW; CDC Prevention Epicenters Program.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):353-355. doi: 10.1017/ice.2016.276. Epub 2016 Nov 28.

PMID:
27890038
5.

The Treadmill Fatigue Test: A Simple, High-throughput Assay of Fatigue-like Behavior for the Mouse.

Dougherty JP, Springer DA, Gershengorn MC.

J Vis Exp. 2016 May 31;(111). doi: 10.3791/54052.

6.

The Experience of Siblings of Children With Type 1 Diabetes.

Dougherty JP.

Pediatr Nurs. 2015 Nov-Dec;41(6):279-82, 305.

PMID:
26837097
7.

Telemedicine for adolescents with type 1 diabetes.

Dougherty JP, Lipman TH, Hyams S, Montgomery KA.

West J Nurs Res. 2014 Oct;36(9):1199-221. doi: 10.1177/0193945914528387. Epub 2014 Apr 1.

PMID:
24695401
8.

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.

Miller LK, Kobayashi Y, Chen CC, Russnak TA, Ron Y, Dougherty JP.

Retrovirology. 2013 Oct 24;10:120. doi: 10.1186/1742-4690-10-120.

9.

Chronic treatment with the serotonin 2A/2C receptor antagonist SR 46349B enhances the retention and efficiency of rule-guided behavior in mice.

Dougherty JP, Oristaglio J.

Neurobiol Learn Mem. 2013 Jul;103:50-63. doi: 10.1016/j.nlm.2013.04.002. Epub 2013 Apr 12.

PMID:
23587729
10.

Oh, their aching backs! occupational injuries in nursing assistants.

Graham P, Dougherty JP.

Orthop Nurs. 2012 Jul-Aug;31(4):218-23. doi: 10.1097/NOR.0b013e31825dfd7a.

PMID:
22828524
11.

Pharmaceutical therapies to recode nonsense mutations in inherited diseases.

Lee HL, Dougherty JP.

Pharmacol Ther. 2012 Nov;136(2):227-66. doi: 10.1016/j.pharmthera.2012.07.007. Epub 2012 Jul 20. Review.

PMID:
22820013
12.

Post-transcriptionally regulated expression system in human xenogeneic transplantation models.

Lee HL, Chen CC, Baasov T, Ron Y, Dougherty JP.

Mol Ther. 2011 Sep;19(9):1645-55. doi: 10.1038/mt.2011.90. Epub 2011 May 17.

13.

High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor.

Micheva-Viteva S, Kobayashi Y, Edelstein LC, Pacchia AL, Lee HL, Graci JD, Breslin J, Phelan BD, Miller LK, Colacino JM, Gu Z, Ron Y, Peltz SW, Dougherty JP.

J Biol Chem. 2011 Jun 17;286(24):21083-91. doi: 10.1074/jbc.M110.195537. Epub 2011 Apr 15.

14.

Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.

Dougherty JP, Aloyo VJ.

Psychopharmacology (Berl). 2011 Jun;215(3):581-93. doi: 10.1007/s00213-011-2207-6. Epub 2011 Feb 22.

PMID:
21340474
15.

A paradigm shift in nursing education: a new model.

Stanley MJ, Dougherty JP.

Nurs Educ Perspect. 2010 Nov-Dec;31(6):378-80.

PMID:
21280445
16.

Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency.

Klartag A, Chen CC, Dougherty JP, Ron Y.

Autoimmunity. 2010 Mar;43(2):164-71. doi: 10.3109/08916930903277329.

PMID:
19824874
17.

Short communication: activation of latent HIV type 1 gene expression by suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor approved for use to treat cutaneous T cell lymphoma.

Edelstein LC, Micheva-Viteva S, Phelan BD, Dougherty JP.

AIDS Res Hum Retroviruses. 2009 Sep;25(9):883-7. doi: 10.1089/aid.2008.0294.

18.

HIV type-1 latency: targeted induction of proviral reservoirs.

Graci JD, Colacino JM, Peltz SW, Dougherty JP, Gu Z.

Antivir Chem Chemother. 2009;19(5):177-87. Review.

PMID:
19483266
19.

Proviral progeny of heterodimeric virions reveal a high crossover rate for human immunodeficiency virus type 2.

Mukherjee S, Lee HL, Ron Y, Dougherty JP.

J Virol. 2006 Dec;80(24):12402-7. Epub 2006 Oct 4.

20.

A HIV-2-based self-inactivating vector for enhanced gene transduction.

Mukherjee S, Lee HL, Pacchia AL, Ron Y, Dougherty JP.

J Biotechnol. 2007 Jan 20;127(4):745-57. Epub 2006 Sep 18.

PMID:
16979253
21.

High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy.

Zhuang J, Mukherjee S, Ron Y, Dougherty JP.

J Virol. 2006 Jul;80(13):6706-11.

22.

Human immunodeficiency virus type 1 latency model for high-throughput screening.

Micheva-Viteva S, Pacchia AL, Ron Y, Peltz SW, Dougherty JP.

Antimicrob Agents Chemother. 2005 Dec;49(12):5185-8.

23.

Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability.

Duttagupta R, Tian B, Wilusz CJ, Khounh DT, Soteropoulos P, Ouyang M, Dougherty JP, Peltz SW.

Mol Cell Biol. 2005 Jul;25(13):5499-513.

24.

A newly discovered function for RNase L in regulating translation termination.

Le Roy F, Salehzada T, Bisbal C, Dougherty JP, Peltz SW.

Nat Struct Mol Biol. 2005 Jun;12(6):505-12. Epub 2005 May 22.

PMID:
15908960
25.

Complete protection from relapsing experimental autoimmune encephalomyelitis induced by syngeneic B cells expressing the autoantigen.

Chen CC, Rivera A, Dougherty JP, Ron Y.

Blood. 2004 Jun 15;103(12):4616-8. Epub 2004 Feb 26.

PMID:
14988158
26.
27.

Choice and use of appropriate packaging cell types.

Pacchia AL, Mukherjee S, Dougherty JP.

Methods Mol Biol. 2003;229:29-42. No abstract available.

PMID:
12824619
28.

Repopulation of rat liver by fetal hepatoblasts and adult hepatocytes transduced ex vivo with lentiviral vectors.

Oertel M, Rosencrantz R, Chen YQ, Thota PN, Sandhu JS, Dabeva MD, Pacchia AL, Adelson ME, Dougherty JP, Shafritz DA.

Hepatology. 2003 May;37(5):994-1005.

PMID:
12717380
29.

Host stem cells can selectively reconstitute missing lymphoid lineages in irradiation bone marrow chimeras.

Rivera A, Chen CC, Dougherty JP, Ben-Nun A, Ron Y.

Blood. 2003 Jun 1;101(11):4347-54. Epub 2003 Feb 13.

PMID:
12586634
30.

Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1.

Adelson ME, Pacchia AL, Kaul M, Rando RF, Ron Y, Peltz SW, Dougherty JP.

Antimicrob Agents Chemother. 2003 Feb;47(2):501-8.

31.

Asthma is a serious disease....

Dougherty JP.

Nasnewsletter. 2002 Nov;17(6):6. No abstract available.

PMID:
12484097
32.

Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots.

Zhuang J, Jetzt AE, Sun G, Yu H, Klarmann G, Ron Y, Preston BD, Dougherty JP.

J Virol. 2002 Nov;76(22):11273-82.

33.

Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesis.

O'Neil PK, Sun G, Yu H, Ron Y, Dougherty JP, Preston BD.

J Biol Chem. 2002 Oct 11;277(41):38053-61. Epub 2002 Jul 31.

34.

Talking with your child's health care provider.

Dougherty JP.

Nasnewsletter. 2002 Jul;17(4):4. No abstract available.

PMID:
12138611
35.

Keeping children safe in summer: prevention is the best medicine.

Dougherty JP.

Nasnewsletter. 2002 May;17(3):5. No abstract available.

PMID:
12035426
36.

Asthma in school children: it's important to re recognize the seriousness of this disease.

Dougherty JP.

Nasnewsletter. 2002 Mar;17(2):6. No abstract available.

PMID:
11950083
38.

Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector.

Sun G, O'Neil PK, Yu H, Ron Y, Preston BD, Dougherty JP.

J Virol. 2001 Dec;75(23):11902-6.

39.
40.

A gene therapy approach for treating T-cell-mediated autoimmune diseases.

Chen C, Rivera A, Ron N, Dougherty JP, Ron Y.

Blood. 2001 Feb 15;97(4):886-94.

PMID:
11159513
41.

High rate of recombination throughout the human immunodeficiency virus type 1 genome.

Jetzt AE, Yu H, Klarmann GJ, Ron Y, Preston BD, Dougherty JP.

J Virol. 2000 Feb;74(3):1234-40.

42.

Antisense translates into sense.

Peltz SW, Dougherty JP.

J Exp Med. 1999 Dec 20;190(12):1729-32. No abstract available.

43.

Long-term contribution to the myeloid compartment by lineage-committed stem cells.

Chen CC, Rivera A, Ron N, Sutkowski N, Dougherty JP, Ron Y.

Blood. 1998 Nov 1;92(9):3210-7.

PMID:
9787157
44.

The nature of human immunodeficiency virus type 1 strand transfers.

Yu H, Jetzt AE, Ron Y, Preston BD, Dougherty JP.

J Biol Chem. 1998 Oct 23;273(43):28384-91.

45.

Regulated lentiviral packaging cell line devoid of most viral cis-acting sequences.

Kaul M, Yu H, Ron Y, Dougherty JP.

Virology. 1998 Sep 15;249(1):167-74.

46.

N2- and C8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo.

He GX, Krawczyk SH, Swaminathan S, Shea RG, Dougherty JP, Terhorst T, Law VS, Griffin LC, Coutré S, Bischofberger N.

J Med Chem. 1998 Jun 18;41(13):2234-42.

PMID:
9632356
47.
48.

Use of single-cycle analysis to study rates and mechanisms of retroviral mutation.

Yu H, Jetzt AE, Dougherty JP.

Methods. 1997 Aug;12(4):325-36. Review.

PMID:
9245613
49.

A murine model for genetic manipulation of the T cell compartment.

Gu J, Kuo ML, Rivera A, Sutkowski N, Ron Y, Dougherty JP.

Exp Hematol. 1996 Oct;24(12):1432-40.

PMID:
8913290
50.

Inducible human immunodeficiency virus type 1 packaging cell lines.

Yu H, Rabson AB, Kaul M, Ron Y, Dougherty JP.

J Virol. 1996 Jul;70(7):4530-7.

Supplemental Content

Loading ...
Support Center